Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas

A case control study

Ju Hyun Lee, Seho Park, Hyung S. Park, Byeongwoo Park

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Background: Infiltrating lobular carcinoma (ILC) is the second most common type of invasive breast cancers and it has been reported to have some unique biologic and epidemiologic characteristics.Methods: Clinicopathological features of 95 patients with ILC, their relapse free survival (RFS) and overall survival (OS) were retrospectively investigated and compared with those of 3,621 patients with infiltrating ductal carcinoma-not otherwise specified (IDC-NOS) between January 1984 and December 2005.Results: ILC constitutes 2.3% of all invasive breast cancers. There were no difference between the ILC and the IDC-NOS groups regarding age at diagnosis, tumor size, nodal status, and treatment modalities except hormone therapy. The ILC group showed more estrogen receptor expression, less HER-2 expression and higher bilaterality. RFS and OS of the ILC patients were similar to those of the IDC. IDC-NOS metastasized more frequently to the lung and bone, whereas, ILC to the bone and ovary.Conclusions: The incidence of ILC was relatively low in Korean breast cancer patients. Comparing to IDC-NOS ILC showed some different features such as higher estrogen receptor expression, less HER-2 expression, higher bilaterality and preferred metastatic sites of bone and ovary. Contralateral cancers and bone and ovary evaluation should be considered when monitoring ILC patients.

Original languageEnglish
Article number1477
JournalWorld Journal of Surgical Oncology
Volume8
DOIs
Publication statusPublished - 2010 Apr 27

Fingerprint

Lobular Carcinoma
Ductal Carcinoma
Case-Control Studies
Survival
Breast Neoplasms
Bone and Bones
Estrogen Receptors
Ovary
Recurrence
Bone Neoplasms
Ovarian Neoplasms
Age Groups
Hormones

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

@article{43839547e5cf49f4a2c6c8f465f2761a,
title = "Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas: A case control study",
abstract = "Background: Infiltrating lobular carcinoma (ILC) is the second most common type of invasive breast cancers and it has been reported to have some unique biologic and epidemiologic characteristics.Methods: Clinicopathological features of 95 patients with ILC, their relapse free survival (RFS) and overall survival (OS) were retrospectively investigated and compared with those of 3,621 patients with infiltrating ductal carcinoma-not otherwise specified (IDC-NOS) between January 1984 and December 2005.Results: ILC constitutes 2.3{\%} of all invasive breast cancers. There were no difference between the ILC and the IDC-NOS groups regarding age at diagnosis, tumor size, nodal status, and treatment modalities except hormone therapy. The ILC group showed more estrogen receptor expression, less HER-2 expression and higher bilaterality. RFS and OS of the ILC patients were similar to those of the IDC. IDC-NOS metastasized more frequently to the lung and bone, whereas, ILC to the bone and ovary.Conclusions: The incidence of ILC was relatively low in Korean breast cancer patients. Comparing to IDC-NOS ILC showed some different features such as higher estrogen receptor expression, less HER-2 expression, higher bilaterality and preferred metastatic sites of bone and ovary. Contralateral cancers and bone and ovary evaluation should be considered when monitoring ILC patients.",
author = "Lee, {Ju Hyun} and Seho Park and Park, {Hyung S.} and Byeongwoo Park",
year = "2010",
month = "4",
day = "27",
doi = "10.1186/1477-7819-8-34",
language = "English",
volume = "8",
journal = "World Journal of Surgical Oncology",
issn = "1477-7819",
publisher = "BioMed Central",

}

Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas : A case control study. / Lee, Ju Hyun; Park, Seho; Park, Hyung S.; Park, Byeongwoo.

In: World Journal of Surgical Oncology, Vol. 8, 1477, 27.04.2010.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinicopathological features of infiltrating lobular carcinomas comparing with infiltrating ductal carcinomas

T2 - A case control study

AU - Lee, Ju Hyun

AU - Park, Seho

AU - Park, Hyung S.

AU - Park, Byeongwoo

PY - 2010/4/27

Y1 - 2010/4/27

N2 - Background: Infiltrating lobular carcinoma (ILC) is the second most common type of invasive breast cancers and it has been reported to have some unique biologic and epidemiologic characteristics.Methods: Clinicopathological features of 95 patients with ILC, their relapse free survival (RFS) and overall survival (OS) were retrospectively investigated and compared with those of 3,621 patients with infiltrating ductal carcinoma-not otherwise specified (IDC-NOS) between January 1984 and December 2005.Results: ILC constitutes 2.3% of all invasive breast cancers. There were no difference between the ILC and the IDC-NOS groups regarding age at diagnosis, tumor size, nodal status, and treatment modalities except hormone therapy. The ILC group showed more estrogen receptor expression, less HER-2 expression and higher bilaterality. RFS and OS of the ILC patients were similar to those of the IDC. IDC-NOS metastasized more frequently to the lung and bone, whereas, ILC to the bone and ovary.Conclusions: The incidence of ILC was relatively low in Korean breast cancer patients. Comparing to IDC-NOS ILC showed some different features such as higher estrogen receptor expression, less HER-2 expression, higher bilaterality and preferred metastatic sites of bone and ovary. Contralateral cancers and bone and ovary evaluation should be considered when monitoring ILC patients.

AB - Background: Infiltrating lobular carcinoma (ILC) is the second most common type of invasive breast cancers and it has been reported to have some unique biologic and epidemiologic characteristics.Methods: Clinicopathological features of 95 patients with ILC, their relapse free survival (RFS) and overall survival (OS) were retrospectively investigated and compared with those of 3,621 patients with infiltrating ductal carcinoma-not otherwise specified (IDC-NOS) between January 1984 and December 2005.Results: ILC constitutes 2.3% of all invasive breast cancers. There were no difference between the ILC and the IDC-NOS groups regarding age at diagnosis, tumor size, nodal status, and treatment modalities except hormone therapy. The ILC group showed more estrogen receptor expression, less HER-2 expression and higher bilaterality. RFS and OS of the ILC patients were similar to those of the IDC. IDC-NOS metastasized more frequently to the lung and bone, whereas, ILC to the bone and ovary.Conclusions: The incidence of ILC was relatively low in Korean breast cancer patients. Comparing to IDC-NOS ILC showed some different features such as higher estrogen receptor expression, less HER-2 expression, higher bilaterality and preferred metastatic sites of bone and ovary. Contralateral cancers and bone and ovary evaluation should be considered when monitoring ILC patients.

UR - http://www.scopus.com/inward/record.url?scp=77951251893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951251893&partnerID=8YFLogxK

U2 - 10.1186/1477-7819-8-34

DO - 10.1186/1477-7819-8-34

M3 - Article

VL - 8

JO - World Journal of Surgical Oncology

JF - World Journal of Surgical Oncology

SN - 1477-7819

M1 - 1477

ER -